Skip to main content
. 2019 May 29;4(7):620–627. doi: 10.1001/jamacardio.2019.1581

Table. Clinical Characteristics of Patients With Calcific Aortic Valve Stenosis, First-Degree Relatives, and a Control Group With Low Lipoprotein(a) (Lp[a]) Levels.

Characteristic Participants, No. (%)
Patients With CAVS First-Degree Relatives Control Participants With Low Lp(a) Levels
All Without CAVS
No. 17 33 27 23
Age, mean (SD), y 71.6 (7.7) 63.9 (8.8) 63.1 (8.7) 60.6 (5.8)
Male, No. (%) 11 (64.7) 22 (66.7) 17 (63.0) 14 (60.9)
BMI, mean (SD) 30.8 (5.4) 29.3 (4.8) 29.4 (5.1) 28.1 (4.5)
Hypertension 16 (94.1) 18 (54.6) 14 (51.9) 8 (34.8)
Diabetes mellitus 4 (23.5) 6 (18.2) 4 (14.8) 2 (8.7)
Coronary artery disease 11 (64.7) 8 (24.2)a 6 (22.2) 1 (4.4)
Stroke 0 0 0 1 (4.4)
Active smokers 0 3 (9.1) 3 (11.1) 3 (13.0)
Lipid-lowering therapy 12 (70.6) 18 (54.6) 14 (51.9) 8 (34.8)
Aortic valve, mean (SD)
Peak gradient, mm Hg 38.9 (17.3) 17.3 (16.9)b 10.3 (4.8)c 7.7 (2.4)
Mean gradient, mm Hg 21.8 (10.5) 9.4 (9.6)d 5.4 (2.6)e 4.2 (1.3)
Area, cm2 1.07 (0.39) 1.96 (0.74)f 2.20 (0.60) 2.41 (0.49)
Lipoprotein(a), median (interquartile range), mg/dL 93.4 (77.3-109.8) 36.7 (2.7-79.2)g 37.0 (3.6-86.7)h 3.1 (2.0-4.8)

Abbreviations: BMI, body mass index (calculated as weight in kilograms divided by height in meters squared); CAVS, calcific aortic valve stenosis.

a

P = .046 for first-degree relatives vs controls with low Lp(a) levels.

b

P = .003 for first-degree relatives vs controls with low Lp(a) levels.

c

P = .02 for first-degree relatives without CAVS vs controls with low Lp(a) levels.

d

P = .004 for first-degree relatives vs controls with low Lp(a) levels.

e

P = .03 for first-degree relatives without CAVS vs controls with low Lp(a) levels.

f

P = .02 for first-degree relatives vs controls with low Lp(a) levels.

g

P < .001 for first-degree relatives vs controls with low Lp(a) levels.

h

P < .001 for first-degree relatives without CAVS vs controls with low Lp(a) levels.